Latest filing published 29 Jun 2022 for ExpreS2ion Biotech Holding AB (EXPRS2), €84k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
AR CONSULT ApS: trading record in brief
This profile gathers the share dealings of AR CONSULT ApS across 2 companies, led by ExpreS2ion Biotech Holding AB (EXPRS2) and ExpreS2ion Biotech Holding AB. Over a trading history stretching from 9 October 2020 to 29 June 2022, the count stands at 19 filings.
On the open market, the record shows 5 purchases worth €101k and 9 sales worth €440k. Netting one side against the other leaves €339k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2022 to date brings 1 purchase and 5 sales.
A typical purchase (the median) is worth €20k. Of 4 purchases, 2 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The latest filing, published on 29 June 2022, reports an open-market sale of €84k in ExpreS2ion Biotech Holding AB (EXPRS2). The most recent open-market purchase was published on 20 April 2022, 1,663 days ago. Filings reach the Finansinspektionen feed a median of 2 days after the trade. The regulation allows three business days to notify a trade (MAR article 19). A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to AR CONSULT ApS
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 75,145 shares@ SEK 12.0017.7% of flowAktieISIN SE0008348262FI:csv-93326d66310d95375eae
- 8,755 shares@ SEK 12.002.1% of flowAktieISIN SE0008348262FI:csv-2a52e99215a4b987954e
- 181,967 shares@ SEK 0.01960.1% of flowTeckningsrätt/UniträttISIN SE0017780679FI:csv-ce9107512297a3fa65ac
- 280,000 shares@ SEK 0.04560.3% of flowTeckningsrätt/UniträttISIN SE0017780679FI:csv-d3b07815734105a97dbe
- 17,501 shares@ SEK 0.36450.1% of flowTeckningsrätt/UniträttISIN SE0017780679FI:csv-2579f51c37c6d1b9e88fCanonical exit: 18 Jul 2022 (T+90)
- 3,700 shares@ SEK 25.001.9% of flowAktieISIN SE0008348262FI:csv-4efc2bcd3a990db0ef0f
- 11,100 shares0WarrantISIN SE0014958336FI:csv-627dcfe9d99d1d769e01
- 7,561 shares@ SEK 49.94117.8% of flowAktieISIN SE0008348262FI:csv-69b69adc10a4715dde8b
- 4,103 shares@ SEK 50.01344.2% of flowAktieISIN SE0008348262FI:csv-5c122c4a1e2a4355a957
- 33,764 shares@ SEK 50.006334.7% of flowAktieISIN SE0008348262FI:csv-bbd8128421f21a95b681
- 3,700 shares@ SEK 22.001.7% of flowAktieISIN SE0008348262FI:csv-ef99b279473c09bd1d41Canonical exit: 12 Jul 2021 (T+90)
- 30,000 shares@ SEK 41.010525.4% of flowAktieISIN SE0008348262FI:csv-7d56884bb1f5b0e94783
- 18,300 shares@ SEK 11.2072100.0% of flowAktieISIN SE0008348262FI:csv-805aee5aab3393007c8eCanonical exit: 17 Feb 2021 (T+90)
- 11,100 shares0WarrantISIN SE0014958328FI:csv-cff42f67ea01fa5e8a53
- 11,100 shares0WarrantISIN SE0014958336FI:csv-671d15357069f44060c5
- 22,200 shares@ SEK 12.0035.6% of flowAktieISIN SE0008348262FI:csv-a66bce781a102d59e4f2Canonical exit: 17 Jan 2021 (T+90)
- 40,200 shares@ SEK 12.0064.4% of flowAktieISIN SE0008348262FI:csv-5f4644b3b44947044f9fCanonical exit: 17 Jan 2021 (T+90)
- 1,272,809 shares0TeckningsrättISIN SE0014957957FI:csv-e5111f06915416cd3d5d
18 of 18 declarations